Woodley Farra Manion Portfolio Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.11M Buy
23,506
+307
+1% +$68.1K 0.25% 49
2025
Q4
$5.3M Buy
23,199
+8,453
+57% +$1.93M 0.25% 43
2025
Q3
$3.41M Buy
14,746
+11,527
+358% +$2.35M 0.16% 59
2025
Q2
$598K Hold
3,219
0.03% 77
2025
Q1
$674K Hold
3,219
0.03% 72
2024
Q4
$572K Hold
3,219
0.03% 71
2024
Q3
$636K Hold
3,219
0.03% 71
2024
Q2
$552K Hold
3,219
0.03% 72
2024
Q1
$586K Sell
3,219
-42
-1% -$7.24K 0.03% 75
2023
Q4
$505K Sell
3,261
-84
-3% -$12.2K 0.03% 76
2023
Q3
$499K Buy
3,345
+530
+19% +$77.8K 0.03% 72
2023
Q2
$379K Sell
2,815
-1,231
-30% -$181K 0.02% 78
2023
Q1
$645K Sell
4,046
-118
-3% -$18K 0.04% 64
2022
Q4
$673K Buy
4,164
+18
+0.4% +$2.76K 0.05% 61
2022
Q3
$556K Sell
4,146
-73
-2% -$10.5K 0.05% 63
2022
Q2
$646K Buy
4,219
+40
+1% +$6.11K 0.05% 59
2022
Q1
$677K Sell
4,179
-715
-15% -$104K 0.05% 62
2021
Q4
$663K Buy
4,894
+2,730
+126% +$322K 0.05% 64
2021
Q3
$233K Sell
2,164
-200
-8% -$22.9K 0.02% 89
2021
Q2
$266K Buy
2,364
+400
+20% +$45K 0.02% 88
2021
Q1
$213K Sell
1,964
-155
-7% -$16.6K 0.02% 98
2020
Q4
$227K Sell
2,119
-231
-10% -$22.2K 0.02% 84
2020
Q3
$206K Sell
2,350
-33
-1% -$3.11K 0.02% 77
2020
Q2
$234K Hold
2,383
0.02% 71
2020
Q1
$182K Sell
2,383
-221
-8% -$18.8K 0.02% 78
2019
Q4
$231K Buy
+2,604
New +$216K 0.02% 83
2014
Q1
Sell
-6,356
Closed -$336K 82
2013
Q4
$336K Hold
6,356
0.06% 71
2013
Q3
$284K Buy
+6,356
New +$282K 0.06% 66

Other funds holding ABBV

Woodley Farra Manion Portfolio Management's ABBV Position: Q1 2026 in Review

Woodley Farra Manion Portfolio Management increased its AbbVie (ABBV) stake by 1.3% in Q1 2026, buying an estimated $68.1K and bringing the position to 23,506 shares worth $5.11M. The position accounts for 0.25% of the portfolio, ranked #49.

Woodley Farra Manion Portfolio Management first reported a position in ABBV in Q3 2013 and has held it in 28 quarters since. The position peaked at $5.3M in Q4 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Woodley Farra Manion Portfolio Management held 23,506 shares of AbbVie worth $5.11M as of Q1 2026.
  • Woodley Farra Manion Portfolio Management bought 307 AbbVie shares in Q1 2026, an estimated $68.1K.
  • AbbVie made up 0.25% of Woodley Farra Manion Portfolio Management's portfolio in Q1 2026, its #49 holding.
  • Woodley Farra Manion Portfolio Management first reported a position in AbbVie in Q3 2013 and has held it in 28 quarters since.
  • Woodley Farra Manion Portfolio Management's AbbVie position peaked at $5.3M in Q4 2025.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q1 2026, filed 8 May 2026.